This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Emerging Treatments & Technologies:
Claus M. Larsen,
Mirjam Faulenbach,
Allan Vaag,
Jan A. Ehses,
Marc Y. Donath,
and Thomas Mandrup-Poulsen
Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes Diabetes Care September 2009 32:1663-1668; published ahead of print June 19, 2009, doi:10.2337/dc09-0533